• 폴리머
• /
• 제32권1호
• /
• pp.49-55
• /
• 2008

슈반세포는 강력한 말초신경 재생 효과를 가지고 있다. 그리고 신경 유도관으로 사용된 소장점막하조직(small intestinal submucosa, SIS)은 세포활성을 촉진하는 여러 가지 성장인자를 다량 함유하고 있고 이종이식의 면역 거부반응이 없는 생체물질로서 널리 사용되고 있다. 슈반세포는 Fischer 쥐의 좌골신경으로부터 분리하였고, 순수 배양된 슈반세포를 $2{\times}10^6$ 세포로 계산하여 SIS 스폰지에 파종하였다. 그리고 Fischer 쥐의 좌골신경 5 mm를 제거하여 신경과 제조된 스폰지를 연결하는 신경 외막 봉합을 실시하였다. 그런 후 1, 2주 및 4주 후 재생된 신경을 적출 한 후, H &E 염색과 S-100, GFAP 및 NF 면역조직화학염색을 실시하였다. 그 결과, SIS 스폰지와 슈반세포를 함께 이식한 군(Group II)은 아무것도 이식하지 않은 군(Control II)과 SIS 스폰지만 이식한 군(Group I) 보다 뚜렷한 양성반응을 보였고 손상을 받지 않은 군(Control I)과 별차이가 없는 양상을 보여주었다. 이는 SIS 스폰지와 슈반세포를 함께 이식했을 때 손상된 조직공학적 말초 신경 재생에 중요한 역할을 한 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제38권1호
• /
• pp.35-43
• /
• 2020

Purpose: This retrospective study compares higher-dose whole-brain radiotherapy (hdWBRT) with reduced-dose WBRT (rdWBRT) in terms of clinical efficacy and toxicity profile in patients treated for primary central nervous system lymphoma (PCNSL). Materials and Methods: Radiotherapy followed by high-dose methotrexate (HD-MTX)-based chemotherapy was administered to immunocompetent patients with histologically confirmed PCNSL between 2000 and 2016. Response to chemotherapy was taken into account when prescribing the radiation dose to the whole brain and primary tumor bed. The whole brain dose was ≤23.4 Gy for rdWBRT (n = 20) and >23.4 Gy for hdWBRT (n = 68). Patients manifesting cognitive disturbance, memory impairment and dysarthria were considered to have neurotoxicity. A median follow-up was 3.62 years. Results: The 3-year overall survival (OS) and progression-free survival (PFS) were 70.0% and 48.9% with rdWBRT, and 63.2% and 43.2% with hdWBRT. The 3-year OS and PFS among patients with partial response (n = 45) after chemotherapy were 77.8% and 53.3% with rdWBRT, and 58.3% and 45.8% with hdWBRT (p > 0.05). Among patients with complete response achieved during follow-up, the 3-year freedom from neurotoxicity (FFNT) rate was 94.1% with rdWBRT and 62.4% with hdWBRT. Among patients aged ≥60 years, the 3-year FFNT rate was 87.5% with rdWBRT and 39.1% with hdWBRT (p = 0.49). Neurotoxicity was not observed after rdWBRT in patients aged below 60 years. Conclusion: rdWBRT with tumor bed boost combined with upfront HD-MTX is less neurotoxic and results in effective survival as higher-dose radiotherapy even in partial response after chemotherapy.

• 융합정보논문지
• /
• 제10권2호
• /
• pp.184-192
• /
• 2020

본 연구는 척추측만증 수술에 대한 객관적이고 정량적인 효과 평가 수단으로서 스마트 깔창을 이용한 보행분석 방법(시계열 분석 포함)을 제시한다. 실험 참가자는 척추측만증 환자이며 스마트 깔창을 착용하고 3분 보행검사를 4번(수술전, 수술 후 8일, 16일, 204일), 6분 보행검사를 1번(수술 후 204일) 받았다. 깔창에는 8개의 압력센서, 가속도 및 각속도 센서가 있고, 각각의 측정값을 저장하여 환자의 수술 전후 보행특성(운동역학 및 시공간 변수)을 비교하였다. 분석결과 수술 후 환자의 모든 보행변수가 개선된 것을 알 수 있었고, 6개월 후 추적검사에서 환자의 보행이 더욱 안정된 것을 확인할 수 있었다. 하지만 환자가 오래 걸으면 한쪽 다리의 swing 시간이 다른 쪽에 비해 미세하게 짧은 현상이 다시 나타났는데, 이는 검사를 수행하는 의사의 육안으로는 발견할 수 없는 preclinical한 문제였다. 우리는 이러한 분석 방법을 통해 환자의 개선 정도를 정량적이고 객관적으로 평가할 수 있었고, preclinical한 문제도 찾을 수 있었다. 향후 이러한 분석 방법은 특정 질병의 보행 패턴을 정의하고 감별하여 적절한 치료방법을 결정하는 연구로 이어질 것이다.

• 한국식품영양과학회지
• /
• 제39권3호
• /
• pp.376-382
• /
• 2010

본 연구는 BF-7이 어린이의 장기 및 단기 기억을 현저하게 촉진시킴을 보여주었다. 기존 임상 시험 결과를 통해 입증된 바와 같이 천연 소재인 BF-7의 안전성을 고려할 때, BF-7은 어린이 장기 및 단기 기억력, 기억유지도 및 기억의 효과적 활용 등 전반적인 기억 수행 능력 향상에 도움을 주는 매우 안전하면서 효과가 탁월한 천연소재임을 확인하였다.

• Tuberculosis and Respiratory Diseases
• /
• 제72권1호
• /
• pp.15-23
• /
• 2012

Background: The survival of non-small cell lung cancer (NSCLC) patients with brain metastases is reported to be 3~6 months even with aggressive treatment. Some patients have very short survival after aggressive treatment and reliable prognostic scoring systems for patients with cancer have a strong correlation with outcome, often supporting decision making and treatment recommendations. Methods: A total of one hundred twenty two NSCLC patients with brain metastases who received gamma knife radiosurgery (GKRS) were analyzed. Survival analysis was calculated in all patients for thirteen available prognostic factors and four prognostic scoring systems: score index for radiosurgery (SIR), recursive partitioning analysis (RPA), graded prognostic assessment (GPA), and basic score for brain metastases (BSBM). Results: Age, Karnofsky performance status, largest brain lesion volume, systemic chemotherapy, primary tumor control, and medication of epidermal growth factor receptor tyrosine kinase inhibitor were statistically independent prognostic factors for survival. A multivariate model of SIR and RPA identified significant differences between each group of scores. We found that three-tiered indices such as SIR and RPA are more useful than four-tiered scoring systems (GPA and BSBM). Conclusion: There is little value of RPA class III (most unfavorable group) for the same results of 6-month and 1-year survival rate. Thus, SIR is the most useful index to sort out patients with poorer prognosis. Further prospective trials should be performed to develop a new molecular- and gene-based prognostic index model.

• 한국의학물리학회지:의학물리
• /
• 제24권4호
• /
• pp.265-270
• /
• 2013

방사선수술 치료계획 시 목표체적 윤곽 그리기 과정에서 발생하는 오차를 확인 하기 위하여 작은 목표체적을 고르게 분포시킨 두 경부 팬텀을 제작하였으며, 동일한 팬텀을 사용하여 CT영상 및 MR영상을 획득하고 이를 대표적인 3개의 방사선수술 치료계획시스템에서 작은 목표체적에 대하여 윤곽 그리기 한 후 체적을 측정하여 비교 분석하였다. CT로부터 획득한 이미지를 이용하여 BrainSCAN (노발리스)에서 윤곽 그리기를 하여 체적을 측정한 경우, 체적 평균값은 $2.23{\pm}0.08cm^3$이며, Leksell gamma plan (감마 나이프)은 $2.13{\pm}0.07cm^3$, Multi plan (사이버 나이프)에서 측정한 값은 $2.24{\pm}0.10cm^3$이였다. 또한 MRI로부터 획득한 이미지를 이용하여 BrainSCAN에서 윤곽 그리기를 하여 체적을 측정한 경우, 체적크기의 평균값은 $2.08{\pm}0.06cm^3$이며, Leksell gamma plan은 $1.94{\pm}0.05cm^3$이고 Multi plan에서 측정한 값은 $2.15{\pm}0.06cm^3$이었다. 각 방사선치료계획 시스템에서 CT영상과 MR영상으로부터 측정한 목표체적의 차이는 CT에서 획득한 이미지를 측정한 체적이 MRI보다 평균적으로 6.4% 정도 크게 나타나는 것을 확인하였다. 동일한 영상획득 장비에서 획득한 이미지를 3개의 서로 다른 방사선치료시스템에서 측정한 결과의 차이는 3~6%이었다. 이 결과는 영상을 획득하는 방식과 윤곽을 그릴 때 생기는 오차를 고려하였을 때 임상적으로 수용할 수 있는 범위 내에 들어간다고 판단이 된다.

• 한국의학물리학회지:의학물리
• /
• 제24권4호
• /
• pp.290-294
• /
• 2013

방사선수술은 고 용량의 방사선을 병소의 목표점에 정확하게 주위의 정상조직을 보호하면서 한 번에 혹은 수 차에 거쳐 전달하는 방법이므로 병소 국재에 대한 오차의 크기는 방사선수술에 직접적인 영향을 끼치게 된다. 본 연구에서는 영상유도 국재 장비인 ExacTrac (BrainLab, Germany)을 이용한 척추방사선수술에서 병소 목표점 국재의 오차를 평가하였다. 국재 오차를 최소화 하기위하여 방사선수술 전 '환자위치 확인장치(PPVT)'를 고안하여 부가적으로 사용하였다. 실시간 목표점오차 평가를 위하여 흉추에 전이된 종양에 대한 방사선수술 8례를 대상으로 평가하였다. 그 결과 isocenter 목표점 오차는 횡단면(lateral) 축 방향, 종단면(longitudinal) 축 방향, 수직면(vertical) 축 방향으로 각각 $0.07{\pm}0.17$ mm, $0.11{\pm}0.18$ mm, $0.13{\pm}0.26$ mm이었으며 평균 공간오차는 $0.20{\pm}0.37$ mm이었다. 병소 isocenter의 회전오차(body rotation)는 종단면(longitudinal) 축 방향 $0.14{\pm}0.07^{\circ}$, 횡단면(lateral) 축 방향 $0.11{\pm}0.07^{\circ}$, 환자테이블 각 이동 $0.03{\pm}0.04^{\circ}$로 평균오차는 $0.20{\pm}0.11^{\circ}$이었다. 본 연구결과 영상유도 국재방법을 이용한 척추방사선수술에서의 병소목표점 국재 평균오차는 임상적으로 허용할 수 있는 오차범위 이내 임을 확인하였다.

• Investigative Magnetic Resonance Imaging
• /
• 제19권2호
• /
• pp.88-98
• /
• 2015

Purpose: To compare the interobserver and intraobserver reliability of mean apparent diffusion coefficient (ADC) values using contrast-enhanced (CE) T1 weighted image (WI) and T2WI as structural images between manual and semiautomatic segmentation methods. Materials and Methods: Between January 2011 and May 2013, 28 patients who underwent brain MR with diffusion weighted image (DWI) and were pathologically confirmed as having glioblastoma participated in our study. The ADC values were measured twice in manual and semiautomatic segmentation methods using CE-T1WI and T2WI as structural images to obtain interobserver and intraobserver reliability. Moreover, intraobserver reliabilities of the different segmentation methods were assessed after subgrouping of the patients based on the MR findings. Results: Interobserver and intraobserver reliabilities were high in both manual and semiautomatic segmentation methods on CE-T1WI-based evaluation, while interobserver reliability on T2WI-based evaluation was not high enough to be used in a clinical context. The intraobserver reliability was particularly lower with the T2WI-based semiautomatic segmentation method in the subgroups with involved $lobes{\leq}2$, with partially demarcated tumor borders, poorly demarcated inner margins of the necrotic portion, and with perilesional edema. Conclusion: Both the manual and semiautomatic segmentation methods on CE-T1WI-based evaluation were clinically acceptable in the measurement of mean ADC values with high interobserver and intraobserver reliabilities.

• Investigative Magnetic Resonance Imaging
• /
• 제19권4호
• /
• pp.218-223
• /
• 2015

Purpose: To investigate whether volumetric analysis based on T2WI and contrast-enhanced (CE) T1WI can distinguish between isocitrate dehydrogenase-1 mutation-positive ($IDH1^P$) and -negative ($IDH1^N$) glioblastomas (GBMs). Materials and Methods: We retrospectively enrolled 109 patients with histopathologically proven GBMs after surgery or stereotactic biopsy and preoperative MR imaging. We measured the whole-tumor volume in each patient using a semiautomatic segmentation method based on both T2WI and CE T1WI. We compared the tumor volumes between $IDH1^P$ (n = 12) and $IDH1^N$ (n = 97) GBMs using an unpaired t-test. In addition, we performed receiver operating characteristic (ROC) analysis for the differentiation of $IDH1^P$ and $IDH1^N$ GBMs using the tumor volumes based on T2WI and CE T1WI. Results: The mean tumor volume based on T2WI was larger for $IDH1^P$ GBMs than $IDH1^N$ GBMs ($108.8{\pm}68.1$ and $59.3{\pm}37.3mm^3$, respectively, P = 0.0002). In addition, $IDH1^P$ GBMs had a larger tumor volume on CE T1WI than did $IDH1^N$ tumors ($49.00{\pm}40.14$ and $22.53{\pm}17.51mm^3$, respectively, P < 0.0001). ROC analysis revealed that the tumor volume based on T2WI could distinguish $IDH1^P$ from $IDH1^N$ with a cutoff value of 90.25 (P < 0.05): 7 of 12 $IDH1^P$ (58.3%) and 79 of 97 $IDH1^N$ (81.4%). Conclusion: Volumetric analysis of T2WI and CE T1WI could enable $IDH1^P$ GBMs to be distinguished from $IDH1^N$ GBMs. We assumed that secondary GBMs with $IDH1^P$ underwent stepwise progression and were more infiltrative than those with $IDH1^N$, which might have resulted in the differences in tumor volume.

• Investigative Magnetic Resonance Imaging
• /
• 제22권2호
• /
• pp.102-109
• /
• 2018

Purpose: The purpose of this study is to compare the performance of the T1 3D subtraction technique and the conventional 2D dynamic contrast enhancement (DCE) technique in diagnosing Cushing's disease. Materials and Methods: Twelve patients with clinically and biochemically proven Cushing's disease were included in the study. In addition, 23 patients with a Rathke's cleft cyst (RCC) diagnosed on an MRI with normal pituitary hormone levels were included as a control, to prevent non-blinded positive results. Postcontrast T1 3D fast spin echo (FSE) images were acquired after DCE images in 3T MRI and image subtraction of pre- and postcontrast T1 3D FSE images were performed. Inter-observer agreement, interpretation time, multiobserver receiver operating characteristic (ROC), and net benefit analyses were performed to compare 2D DCE and T1 3D subtraction techniques. Results: Inter-observer agreement for a visual scale of contrast enhancement was poor in DCE (${\kappa}=0.57$) and good in T1 3D subtraction images (${\kappa}=0.75$). The time taken for determining contrast-enhancement in pituitary lesions was significantly shorter in the T1 3D subtraction images compared to the DCE sequence (P < 0.05). ROC values demonstrated increased reader confidence range with T1 3D subtraction images (95% confidence interval [CI]: 0.94-1.00) compared with DCE (95% CI: 0.70-0.92) (P < 0.01). The net benefit effect of T1 3D subtraction images over DCE was 0.34 (95% CI: 0.12-0.56). For Cushing's disease, both reviewers misclassified one case as a nonenhancing lesion on the DCE images, while no cases were misclassified on T1 3D subtraction images. Conclusion: The T1 3D subtraction technique shows superior performance for determining the presence of enhancement on pituitary lesions compared with conventional DCE techniques, which may aid in diagnosing Cushing's disease.